Increased G3BP2 promoted the growth of cancer cells and high expression level of G3BP2 was associated with poor prognostic in Head and Neck squamous cell carcinoma, prostate cancer, breast, and lung cancer [39–42]. Here, G3BP2 is linked to prostate carcinoma.